Taejon, South Korea

Bong Chan Kim

This inventor holds 1 USPTO granted patent. Top assignee: Lg Chemical Ltd.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bong Chan Kim. Retrieved from https://idiyas.com/inventor/bong-chan-kim-gr4p9l8r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bong Chan Kim: Innovator in Medicinal Chemistry

Introduction

Bong Chan Kim is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative processes in synthesizing chemical compounds.

Latest Patents

One of his key patents is titled "Process for synthesizing para-and/or meta-substituted cyanophenyalanine derivatives." This invention relates to a process for preparing a useful medicinal intermediate, represented by a specific chemical formula. His work in this area has the potential to impact the development of new medicinal compounds.

Career Highlights

Bong Chan Kim is associated with LG Chemical Ltd., a leading company in the chemical industry. His role at the company has allowed him to focus on research and development, contributing to advancements in chemical synthesis and medicinal applications.

Collaborations

Throughout his career, Bong Chan Kim has collaborated with talented individuals such as Sang Yeul Hwang and Jong Chan Lim. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Bong Chan Kim's contributions to medicinal chemistry through his patent and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in chemical synthesis and medicinal applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…